CGI orders withdrawal of cancer drug Olaparib for certain treatments
Cgi orders withdrawal of cancer drug olaparib for certain treatments
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cgi orders withdrawal of cancer drug olaparib for certain treatments
Get latest articles and stories on India at LatestLY. The Drug Controller General of India has asked drug regulators in all states and Union territories to withdraw AstraZeneca's anti-cancer drug Olaparib tablets for treatment in patients who have received three or more prior lines of chemotherapy. India News | DCGI Orders Withdrawal of Cancer Drug Olaparib for Certain Treatments.
India's DCGI orders the withdrawal of Olaparib for specific cancer treatments after reviewing adverse effects and survival data.
DIMAPUR, MAY 3 (MExN): The All India Organization of Chemists and Druggists (AIOCD) has expressed deep concern over the Central government’s proposal to permit the sale of Over-The-Counter (OTC) drugs without a license in India.
India enforced 'Schedule M' for drug manufacturers, emphasizing quality, recall systems. Companies must comply with strict rules on hygiene, audits, and reporting defects to DCGI for improved drug quality and safety measures. For seamless implementation of the new rules, the health ministry has been conducting workshops and giving presentations to pharma companies.